REFERENCES
  1. Levey AS, Atkins R, Coresh J et al. Chronic Kidney as a global public health problem: approaches and initiative a position statement from kidney disease. Improving Global Outcomes. Kidney Int 2007; 72:247-259
  2. De Nicola L, Zoccali C; kidney disease. Prevalence in the general population heterogeneity and concerns. Nephrol Dial transplant 2016; 31:331-335
  3. United States Renal Data system: 2015 USRDS. Annual Data Report: Epidermalogy of kidney disease in the United States. Betheseda, National Institute of Health. 2015: www.usrds.org/2015/vuw/default.aspx(ated October 8, 2016).
  4. National Kidney foundation K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification and stratification. AmJ Kid Dis 2002; 39 (2 suppl) S1-226
  5. Johnson CA, Lovey AS, Coresh J, Levin A, Lau J. Eknoyan G. Clinical Practice guidelines for chronic kidney disease in adults part 1: Definition, disease stages, evaluation, treatment and risk factors. Am Fam physician 2004; 70:869-76
  6. World Health Organization, “Global burden of disease” March 2006. http//www.who.int/whosis/mencfmpatt-evidence.
  7. World Health Organization Consultation of Obesity. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report series 894. World Health Organization, General Switzerland; 2000
  8. Ulasii II, Chinwuba K Ijoma. The enormity of Chronic kidney disease in Nigeria; The situation in a teaching hospital in south east Nigeria. Journal of Tropical Medicine doi: 10.1155/2010/501957;2010
  9. Kadiri S, Arije A, Salako BL. Traditional herbal preparations and acute renal failure in South West Nigeria, Tropical Doctor 1999;29(4): 244-246
  10. Akinsola W, Odesanmi WO, Ogunniyi J.O, Ladipo GO, Akinsola W, Odesanmi WO, Ogunniyi JO, Ladipo GO: Diseases causing chronic renal failure in Nigerians – a prospective study of 100 cases Afrj Med Sci 1989, 18:131-137
  11. Afolabi MO, Abioye-Kuteya EA, Arogundade FA, Bello is prevalence of chronic kidney disease in a Nigerian family practice population. SA Fam Pract 2009; 51(2): 132-139
  12. Ulasi II, Ijoma CK, Onodugo OD, Arodiwe EB, Ifebunandu NA, Towards Prevention of Chronic kidney disease in Nigeria; a community based study in South East Nigeria. Kidney Int 2013; 3(2) 195-201. Doi:http//doi.org/10.1038/kisup 2013.13
  13. Zhang, Q.-L Rothenbacher, D. Prevalence of chronic kidney disease in population-based studies. Systematic review. BMC Public Health.2008;8:117
  14. Sumaili EK, Cohen EP. Screening of Chronic Kidney disease in Sub Saharan Africa. The Lancet 2010; 367:418
  15. Okwuonu CG, Chkwuonye II, Adejumo OA, Agaba EI, Ojogwu LI, Prevalence of chronic kidney disease and its risk factors among adults in a semi-urban community of South East Nigeria. Niger Postgrad Med J. 2017: 24(2): 81-87
  16. Abene EE, Gimba ZM, Agaba PA, et al. Chronic Kidney disease screening: results if the 2013 world kidney day activities conducted at the Jos University Teaching Hospital.Highland Med Res J. 2017: 17(1):1-5
  17. CIA – The World factbook – Nigeria”, May 2005, https://www.cia.gov/library/publications/the-world-factbook/geos/ng.html.
  18. WHO Steps Manual. Cardiovascular disease in developing countries (KHDC PROGRAM) International Soceity of Nephrology, Brussel; 2005
  19. World Health Organization. International Society of Hypertension Writing Group. 2003. World Health Organization/International Society of Hypertension (ISH) statement on management of hypertension J Hypertens. 2003;21:1983-1992
  20. American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004:27-S79-S83 View in Article/Crossref/PubMed/Google Scholar
  21. NCEP Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol (ATP III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment panel III) final report Circulation. 2002:106:3143-3421
  22. Levey AS, Bosih TP, Lewis TB, Greene T, Rogers N, Roth DA, A more accurate method to estimate glomerular filtration rate from serum creatinine; a new prediction equation. Modification of Diet on Renal Disease study Group Ann International Med 1999; 130(6): 461-470, 1999; 13:23-27 Nigeria a revist J Human Hypertension
  23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999:130(6): 461-470.
  24. Kadiri S, Ogunlesi A, Osinfade k et al. the causes and course of acute tubular necrosis in Nigerians. Afr Med Med Sci 1992:21:91-91
  25. Ulasi II, Ijoma UC, Kalu AO, the aetiological relationship between the use of mercury-containing soaps creams and nephritic syndrome Niger Med J 2005; 46:29-32
  26. Advance: Collaboration Group: Patel A, McMahon S, Chalmers J, Neal B, et al. intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N ENgl J Med 2008; 358:2560-2572
  27. World Health Organization. The world Health Report 2002. Reducing Risk, Promoting healthy life. Geneva, Switzerland. World Health Organization 2002.
  28. Fogo A, Breyer JA, Smith MC et al. Accuracy of the diagnosis of American stud of kidney disease (AASK) trial. AASK Pilot Study Investigators. Kidney Int 1997:51:244-252.
  29. Luke RG, hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end stage renal disease. Nephrol Dual Transplant 1999; 14; 2271-2273
  30. Naickers: End-stage renal disease in sub-saharan Africa. Ethn Dis 2009; 19(Supll 1): 13-15
  31. Ogah OS, Okpechi I, Innocent I, Chukwuonye IH, Akinye JO, Onwubere BTC et al Blood pressure, prevalence of hypertension and hypertension related complication in Nigeria Africans: A review, World J. Cardio 2012: 4(12): 327-340
  32. Ulasi II, Ijoma CL, Onwubere BJ, Arodine E, Omudugo O. Okafor L. High Prevalence and Low awareness of hypertension in a market population in Enugu, Nigeria Int. J Hypertens 2011: 2011: 8696
  33. Ezeala-Adika BA, Orjioke C, Ekenze OS, Ijoma U, Onodugo O, Okudo G et al population based of high blood pressure among adult in an urban slum in Enugu South East Nigeria. J. Hum Hyperlasis 2015; 1-7
  34. Federal Ministry of Health. Non-communicable disease in Nigeria. Find report of National Survey Lagos 1997. 1-118
  35. Erhun WO, Olayiwola G, Agbani EO et al. Prevalence of Hypertension in a University Community in South West Nigeria. Afr J Biomedl Res2005;8:15-19.
  36. World Health Orgnization. Cardiovascular Disease (CVDs); 2016 Avaiable from: http://www.who.int/entity/mediacentre/factsheets/fs317/en/index.html. [Last retreived on 2016 Jul 10].
  37. Wang AY. Cardiovascular risk in diabetic end-stage renal disease patients. JDiabetes 2011; 3:119-131
  38. Sicree R, Shaw J, Zimmet P. The global burden: diabetes and impaired glucose tolerance. IDF Diabetes Atlas. 4thedn (online) Available from http://www.idf.org/sites/default/files/The_Global_Burden.pdf(Accessed 1 November 2011).
  39. Ervin RB. Prevalence of metabolic syndrome Among Adults 20 years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003-2006. National Health Statistics Reports.(online) Available from http://www.cdc.gov/nchs/data/nhsr/nhsr013.pdf (Accessed 1 October 2011).
  40. Okafor E.N, Ugonabo M.C, Chukwukelu E.E, diabetic nepropathy in Enugu South East Nigeria. International Journal of Science and Research February2018. 7:(2) Paper Id: ART20179793
  41. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetets: The United Kingdom Prospective Diabetetcs Study Kidney Int 2003: 63:225-32.
  42. Wu Ay, Kong NC, De Leon FA, Pan CY, Tai TY, Yeiung VT, et al, An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: The microalbuminuria prevalence (MAP) study. Diabetologia 2005. 48:17-26.
  43. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V. D’Errico N, et al., Prevalence and risk factors for micro and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 1996: 19:43-7.
  44. Wei X, Li ZI, Chen W, Mao H, Li Z, Dong X, et al. Prevalence and risk factors of chronic kidney disease in first-degree relatives of chronic kidney disease patients in Southern Chinan Nephrology 2012;17:123-30.
  45. Bello AK, Peters J, Wight J, de Zeeuw D, El Nahas M; European kidney institute. A population-based screening for microalbuminuria among relatives of CKD patients: the kidney evaluation and awareness program in Sheffield (KEAPS). Am J Kidney Dis 2008;52:434-43.
  46. Ualsi II, Tzur S, Wasser WG, Shemer R, Kruzel E, Feigin E, et al. high population frequencies of APOL 1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from South-eastern Nigeria. Nephron Clin Pract 2013; 123:123-8.
  47. Gillerot G, Jadoul M, Arlt VM, van Ypersele De Strihou C, Schmeiser HH, But PP, et al. Aristoochic acid nephropathy in a Chinese patient: Time to abandon the term ‘Chinese herbs nephropathy?. Am J Kidney Dis 2001: 38:E26.
  48. Seedat YK. Acute renal failure among Blacks and Indians in South Africa. SAfr Med J1978; 54:247-2
  49. Wald R, Quinn Kidney Injury NK, Burns KE, Friedrich JO, Garg AX, et al; University of Toronto acute kidney injury research group. Risk of chronic dialysis and death following acute kidney injury. Am J Med. 2012 Jun; 125(6); 585-93 Pubmed/Medline (NLM) Crossref (DOI).
  50. Ulasi II. Toward prevention of chronic kidney disease in Nigeria. A report submitted to international and society of Nephrology (May 2010).
  51. Parazella MA. Renal vulnerability to drug toxicity. Clin J AM Soc Nephrol 2009; 4:1275-1183.
  52. Su T, Zhang L, Li X et al. Regular use of nephrotoxic medication is an independent risk factor for chronic kidney disease-results from a Chinese population study. Nephrol Dial Transplant 2011; 26:1916-1923.
  53. Alasia D.D., Emem-Chioma P.C. and Wokoma F.S 2010. Association of Lead Exposure, Serum Uric Acid and Parameters of Renal Function in Nigerian Lead-Expose Workers. INt. J. Occup. Environ. Med.; 1:182-190.
  54. Okafor EN, Okonkwo IN, Ugonabo MC, Chukwukelu EE, Odurukwe OU, Osiri SN. Emerging Risk risk factors associated with prevalence of hepatitis C virus infection among Nigerians: Findings from blood donors in an academic hospital, Enugu South-Eastern Nigeria. Int J Clin Pract: 2019;00:e13460. https:doi.org/10.1111/ijcp.13460